1. Home
  2. Labeler Index
  3. Camber Pharmaceuticals, Inc.
  4. 31722-377
  5. Product Images: Calcium Acetate

Product Images Calcium Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Calcium Acetate NDC 31722-377 by Camber Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

667mg-200 - 667mg 200ct

667mg-200 - 667mg 200ct

This is a description of a bottle of Calcium Acetate Capsules manufactured by Camber Pharmaceuticals. Each capsule contains 667mg of calcium acetate which is equivalent to 169 mg of calcium. The prescription medication should be taken strictly as per the physician's directions, and it should not be chewed. The storage instruction is to keep it at a controlled room temperature between 20°C to 25°C. The text has a National Drug Code (NDC) number of 31722-377-02. The description contains necessary details such as the number of capsules (200), and the location of the manufacturer.*

667mg-60 - 667mg 60ct

667mg-60 - 667mg 60ct

This is a medication label for Calcium Acetate capsules. Each capsule contains 667g of Calcium Acetate equivalent to 169mg of calcium. The label includes directions to take the medication as prescribed by a physician and warns to keep the medication out of reach of children. The capsules should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The medication is manufactured for Canber Prarmaseutas by InvaGen and comes in a bottle containing 60 capsules. This medication is available by prescription only.*

Table 1 - Table1

Table 1 - Table1

This appears to be a table showing adverse reactions in patients with end-stage renal disease who underwent hemodialysis. The table lists the preferred term for the reaction, the total number of adverse reactions reported, and some data from two different studies involving calcium acetate. The adverse reactions listed in the table include nausea, vomiting, and hypercalcemia.*

Table 2 - Table2

Table 2 - Table2

Table 2 shows the average serum phosphorus and calcium levels at pre-study, interim, and study completion time points. The table displays the parameter with the corresponding weeks and p-values for each parameter. The mean values are expressed as SE, and 91 patients completed at least 6 weeks of the study. ANOVA was used to analyze the difference in values at pre-study and study completion.*

Table 3 - Table3

Table 3 - Table3

This is a table showing serum phosphorus and calcium levels before and after treatment with calcium acetate and placebo. The values are expressed as mean and standard error of the mean (SEM). ANOVA analysis was performed to compare the effects of calcium acetate and placebo after two weeks of treatment.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.